Results 141 to 150 of about 5,894 (213)

Neuroleptic Malignant Syndrome on Chronic Trifluoperazine Therapy: A Diagnostic Dilemma. [PDF]

Clin Case Rep
Baral S, Bhattarai S, Joshi KC.
europepmc   +1 more source

Preliminary observations of glucose metabolism dysregulation in pediatric Huntington's disease. [PDF]

Front Neurol
Graziola F, Danti FR, Penzo M, Spagarino A, Minacapilli E, Moscatelli M, Zibordi F, Mariotti C, Zorzi G.   +8 more
europepmc   +1 more source

Valbenazine induced acute parkinsonism in a patient with alcohol use disorder and central pontine myelinolysis. [PDF]

PCN Rep
Nagai Y, Mamiko M, Miyakawa K.
europepmc   +1 more source

Mapping dysphagia in pediatric dystonia. [PDF]

PLoS One
Keles MN, Serdaroglu E.
europepmc   +1 more source

Managing Dystonia in Partington Syndrome. [PDF]

Mov Disord Clin Pract
Pichon E, Alioth A, Catalano Chiuvé S, Zacharia A, Ruiz-Lopez M, Breen DP, Zangas-Gehri F, Draye F, Curie A, Wilson D, Fung VSC, Duma S, Fluss J, Bally JF.   +13 more
europepmc   +1 more source

From Seizures to Behavioral Symptoms: A Case Series of Psychiatric Adverse Effects of Levetiracetam in Epilepsy Patients. [PDF]

Cureus
Ganjikunta RK, Udaragudi RD, Chalivendra P, Kaveti UR, K Mallaram G.   +4 more
europepmc   +1 more source

Untangling late-onset first-episode mania: A case series. [PDF]

Indian J Psychiatry
Khandelwal H, Tyagi S, Kaur H, Verma V, Nebhinani N, Suthar N, Gehlawat P.   +6 more
europepmc   +1 more source

Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency [PDF]

, 2017
et al,, Pearson, Toni S
core   +1 more source

Expanding the Genetic and Phenotypic Spectrum of DYT-VPS16: The Importance of Splice-Site Variants. [PDF]

Mov Disord
Westenberger A, Verdura E, Radefeldt M, Sanderson LE, Tripolszki K, Marcé-Grau A, Cazurro-Gutiérrez A, Nikoncuk A, Herzog R, Al-Ali R, Ferreira M, Almeida LS, Silveira TRD, Khan S, Maia RD, Klivényi P, Salamon A, Baltaci V, Subasioglu A, Prada-Arismendy J, Čuturilo G, Loens S, Tadic V, Maystadt I, Karadurmus D, Leube B, De Winter J, Monticelli A, De Waele L, Baets J, Vinkšel M, Maver A, Tschopp L, Ziegler G, Sanguinetti A, Lohmann K, Barakat TS, Bauer P, Perez-Dueñas B, Bertoli-Avella AM.   +39 more
europepmc   +1 more source

QSPR analysis of physico-chemical and pharmacological properties of medications for Parkinson's treatment utilizing neighborhood degree-based topological descriptors. [PDF]

Sci Rep
Ravi V, Chidambaram N.
europepmc   +1 more source